The Institut de Recerca of the Vall Dhebron University Hospital (VHIR) starts the greater farmacogenético study on ADHD.
el Institut de Recerca of the Hospital Vall d ’ Hebron (VHIR) starts the greater farmacogenético study on ADHD. -the study of larger level international nacionale, carried out with the greatest number of patient’s with ADHD: 1,200 patients, 360 patients with ADHD and 360 subjects cont role -the first study that investigates the genes involves two in ADHD jointly – in 76% of cases, and l ADHD has a strong base genéti ca. Knowing the genes of each patient is vital for a personalised treatment -the results of this study will allow n help in the treatment of children with ADHD Barcelona, March 2012.- the Institut de Recerca of the Hospital Vall d ’ Hebron (VHIR) has launched the farmacogenético study on ADHD of larger – in our country and abroad -, from the hand of Dr. Josep Antoni Ramos – Quiroga, Coordinator of the comprehensive programme of the attention deficit to the adults (PIDAA) of the service of Psychiatry of the Hospital Universitari Vall d ’ Hebron. The results will be presented in October 2012, within the framework of national and European Congress of Psychiatry and neuropediatrÃa. The study is intended to confirm that the genetics of each individual determines how the disease manifests how responds to drug treatment and the predisposition to suffer from other disorders. Thus, the results of the DNA analysis of 360 subjects with...
Read More